
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>In their comprehensive review of antithrombotic agents following acute coronary syndromes, Matteau and Bhatt[1][1] discuss the drug interaction between proton pump inhibitors and clopidogrel. They note that the COGENT trial, led by Bhatt, found no increased risk of major cardiovascular events at six
Clinical Trials as Topic, Drug Combinations, Ticlopidine, Humans, Drug Interactions, Proton Pump Inhibitors, Acute Coronary Syndrome, Pantoprazole, 2-Pyridinylmethylsulfinylbenzimidazoles, Omeprazole, Platelet Aggregation Inhibitors, Clopidogrel
Clinical Trials as Topic, Drug Combinations, Ticlopidine, Humans, Drug Interactions, Proton Pump Inhibitors, Acute Coronary Syndrome, Pantoprazole, 2-Pyridinylmethylsulfinylbenzimidazoles, Omeprazole, Platelet Aggregation Inhibitors, Clopidogrel
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
